Fortimedix Surgical launches product line extension with symphonX™ Instruments short

Fortimedix Surgical today announced the official U.S. launch of its product line extension with symphonX™ Instruments short. The new product line offers shorter instruments that broaden surgical applicability of the symphonX™ Surgical Platform, further increasing the ease of use for surgeons during specific surgical procedures.
Read the full article

Data Demonstrating Feasibility of symphonX™ Based Surgical Platform for TaCR Announced

Fortimedix Surgical today announced cadaver case series results demonstrating feasibility of a symphonX™ based surgical platform for transanal colon resection (TaCR), also presented last week at the American Society For Gastrointestinal Endoscopy (ASGE) NOSCAR Summit in Downers Grove, IL.
Read the full article

Fortimedix Surgical Strengthens U.S. Commercial Team with David Castiglioni as VP Sales

Fortimedix Surgical today announced the appointment of David Castiglioni as Vice President of Sales in the United States. Under Mr. Castiglioni’s leadership, the Fortimedix Surgical commercial team will further expand sales of the symphonX™ Surgical Platform, the company’s flagship product and the world’s lowest profile single-port surgery solution.
Read the full article

Note: FMX314 is the engineering code name for symphonX™ used during the pre-commercial phase.

 Download our Media Kit here. For media inquiries, please contact Marc van de Graaf via +1(858) 414 4989 or via our media(at)

Copyright © Fortimedix Surgical 2018. All rights reserved.


Stay updated about the latest developments and innovations from Fortimedix Surgical - subscribe to our newsletter via our subscription form.

By using our website you consent to all cookies in accordance with our Cookie Policy.